RxDoctor Payments Data

Joshua Port, MD

Orthopaedic Surgery · Altoona, PANPI 1104894229

Payments from drug & device makers

$196,250in general payments, 2019–2025

Across 197 payments — averaging $996.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$93K
  • Endo Pharmaceuticals Inc.$52K
  • GRT US Holding, Inc.$31K
  • Catalyst Orthoscience$16K
  • Mid-atlantic Surgical Systems, LLC$2K
  • Encore Medical, LP$2K
  • plus $846 from 6 others
$2,875in research payments, 2019–2025

Across 3 payments — averaging $958.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$3K

What the payments were for

  • Consulting fees$70,93267%
  • Speaking & faculty fees$18,07317%
  • Travel & lodging$11,71111%
  • Food & beverage$4,6314%
  • Education$1,2581%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$196,250 in reported general payments places this provider in the 90th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$240,184
Medicare patients
366
Services billed
6,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl174$759
Celecoxib37$675
Ondansetron Hcl193$559
Cefadroxil39$469
Doxycycline Monohydrate137$466
ErythromycinErythromycin Base15$295
Ketorolac Tromethamine20$256
Cefazolin Sodium22$149
Dexamethasone Sodium PhosphateDexamethasone Sodium Phosp/Pf20$128
Methylprednisolone17$126
Meloxicam16$68
Gabapentin12$66
Cephalexin15$49
Tramadol Hcl12$25
Doxycycline Hyclate11$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Altoona

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →